Journal
CELLULAR SIGNALLING
Volume 16, Issue 1, Pages 97-104Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0898-6568(03)00090-1
Keywords
phosphorylation; serme/threonine kinase; hyperglycaemia; protein kinase C
Categories
Funding
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, R01DK033651] Funding Source: NIH RePORTER
- NIDDK NIH HHS [DK 33651] Funding Source: Medline
Ask authors/readers for more resources
We analysed the effects of high glucose in rail cells overexpressing insulin receptor. High (25 mM) glucose inhibited insulin-stimulated tyrosine kinase activity completely at insulin concentrations of I and 5 ng/ml. Decapeptides modelled on insulin receptor sequences surrounding serines 1035 and 1270 were found to inhibit protein kinase C activity in vitro and after microinjection into cells blocked the inhibition of mitogenesis induced by glucose. Purification of receptor from 3T3L1 adipocytes revealed that only the isoenzymes beta1, betaII and delta were detected. The site of the interaction was mapped to the catalytic domain of betaII. These results demonstrate that the inhibition of insulin receptor tyrosine kinase activity can be ameliorated using insulin receptor peptide sequences and there is constitutive and differential interaction of individual PKC isoenzymes with the insulin receptor, and in the case of 11, this interaction maps to the catalytic domain rather than the regulatory domain. (C) 2003 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available